BBI-6000

N/A

Report date: 2025/01/26 16:29:23
NME

Base Information

Drug NameBBI-6000
Drug Alias NameROR-gamma Inhibitors (Brickell Biotech)ROR-gamma Inhibitor (Fresh Tracks Therapeutics)ROR-gamma Inhibitor (New York University/Orca Pharmaceuticals)BBI-6000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor gamma inhibitors
TargetsRetinoic acid receptor gamma
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesFresh Tracks Therapeutics Inc
Inactive CompaniesOrca PharmaceuticalsBrickell Subsidiary IncNew York University
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A